Vortioxetine, marketed under the brand name Trintellix, is an antidepressant that has shown efficacy in treating major depressive disorder (MDD) among other mental health conditions.

This blog examines the potential of armodafinil and modafinil, two agents known for promoting wakefulness, in treating ADHD. By reviewing recent research and authoritative sources, we aim to shed light on their effectiveness, dosing, administration timing, potential side effects, and interactions with other medications.

At Philadelphia Integrative Psychiatry, we are dedicated to providing our patients with the most effective and personalized care, guided by the latest research in the field of mental health.